Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001368148-22-000108
Filing Date
2022-08-12
Accepted
2022-08-12 07:07:39
Documents
50
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q athx-20220630.htm   iXBRL 10-Q 763614
2 EX-31.1 ex31120220630.htm EX-31.1 9800
3 EX-32.1 ex32120220630.htm EX-32.1 6724
  Complete submission text file 0001368148-22-000108.txt   3509435

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT athx-20220630.xsd EX-101.SCH 25712
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT athx-20220630_cal.xml EX-101.CAL 33350
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT athx-20220630_def.xml EX-101.DEF 141321
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT athx-20220630_lab.xml EX-101.LAB 332054
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT athx-20220630_pre.xml EX-101.PRE 209964
44 EXTRACTED XBRL INSTANCE DOCUMENT athx-20220630_htm.xml XML 471247
Mailing Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634
Business Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634 216-431-9900
ATHERSYS, INC / NEW (Filer) CIK: 0001368148 (see all company filings)

EIN.: 204864095 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33876 | Film No.: 221157792
SIC: 2834 Pharmaceutical Preparations